Das De Sudeep, Krishna Sreedhar, Jethwa Ankeet
Institute of Public Health, University of Cambridge, UK.
Department of Elderly Medicine, Leeds Teaching Hospitals NHS Trust, UK.
Atherosclerosis. 2015 Feb;238(2):296-303. doi: 10.1016/j.atherosclerosis.2014.12.018. Epub 2014 Dec 20.
Observations in the past have hypothesized an association between body iron status and coronary heart disease (CHD). Epidemiological studies to date have however been inconclusive without the existence of strongly positive or strongly negative associations between iron status and coronary heart disease.
To investigate the association between iron status and coronary heart disease.
A systematic review was performed using the databases PubMed and Cochrane Library. Search terms included iron, ferritin, transferrin, total iron binding capacity, coronary heart disease and angina.
Only prospective studies investigating the association of body iron status and coronary heart disease were included. All participants were free from coronary heart disease at baseline. There were no language or geographic restrictions imposed on the search strategy.
Independent extraction of articles by 2 authors using predefined data fields.
All pooled analyses were based on random-effects models. A total of 17 studies were identified for analysis, involving a total of 9236 cases of coronary heart disease and 156,427 participants. Several studies reported more than 1 marker of iron status. For serum ferritin, comparison of individuals in the top third versus the bottom third of baseline measurements yielded a combined risk ratio of 1.03 (95%CI, 0.87-1.23) for CHD/MI. For transferrin saturation, the combined risk ratio for CHD/MI was 0.82 (95% CI, 0.75-0.89) for individuals in the top third versus the bottom third of baseline measurements. Comparison of individuals in top and bottom thirds of baseline measurements yielded non-significant risk ratios of studies involving total iron-binding capacity (combined risk ratio, 0.99; 95% CI 0.86-1.13) and serum iron (combined risk ratio, 0.87; 95% CI 0.73-1.04). For serum iron, the combined risk ratio for CHD/MI after excluding the study by Morrisson et al. [1] was 0.80 (95% CI, 0.73-0.87).
The results suggest that there is a negative association of transferrin levels and coronary heart disease with high transferrin saturations being associated with a lower risk of CHD/MI. There was also a negative association of serum iron and CHD/MI after one study [1] was excluded. There is no significant association between the other markers of iron status and CHD. It is however difficult to infer causality from these findings due to limitations in terms of reverse causality bias and residual confounding.
过去的观察结果曾推测机体铁状态与冠心病(CHD)之间存在关联。然而,迄今为止的流行病学研究尚无定论,铁状态与冠心病之间不存在强正相关或强负相关。
研究铁状态与冠心病之间的关联。
使用PubMed和Cochrane图书馆数据库进行系统评价。检索词包括铁、铁蛋白、转铁蛋白、总铁结合力、冠心病和心绞痛。
仅纳入调查机体铁状态与冠心病关联的前瞻性研究。所有参与者在基线时均无冠心病。检索策略未设语言或地域限制。
由2名作者使用预定义数据字段独立提取文章信息。
所有汇总分析均基于随机效应模型。共确定17项研究进行分析,涉及9236例冠心病病例和156427名参与者。几项研究报告了不止一种铁状态标志物。对于血清铁蛋白,比较基线测量值处于前三分之一与后三分之一的个体,冠心病/心肌梗死的合并风险比为1.03(95%CI,0.87 - 1.23)。对于转铁蛋白饱和度,比较基线测量值处于前三分之一与后三分之一的个体,冠心病/心肌梗死的合并风险比为0.82(95%CI,0.75 - 0.89)。比较基线测量值处于前三分之一与后三分之一的个体,涉及总铁结合力(合并风险比,0.99;95%CI 0.86 - 1.13)和血清铁(合并风险比,0.87;95%CI 0.73 - 1.04)的研究风险比无统计学意义。对于血清铁,排除Morrisson等人[1]的研究后,冠心病/心肌梗死的合并风险比为0.80(95%CI,0.73 - 0.87)。
结果表明,转铁蛋白水平与冠心病呈负相关,高转铁蛋白饱和度与较低的冠心病/心肌梗死风险相关。排除一项研究[1]后,血清铁与冠心病/心肌梗死也呈负相关。其他铁状态标志物与冠心病无显著关联。然而,由于存在反向因果偏倚和残余混杂因素,很难从这些发现中推断因果关系。